WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'0601 Infant (under 12 months) mortality rate: 652
GDP / capita (US$): 3'0421 Child (under 5 years) mortality rate: 842

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 3'890  3'796  3'703  3'609  3'516  2'708  2'024  1'534 
Births 133  131  129  127  125  104  83  66 
Surviving infants 123  121  120  118  116  96  76  60 
Pop. less than 5 years 584  575  565  553  543  443  350  273 
Pop. less than 15 years 1'560  1'529  1'497  1'464  1'434  1'159  903  696 
Female 15-49 years 944  920  897  874  849  636  461  346 

Number of reported case

(Click for retrospective incidence data for Mauritania)
Diphtheria 18 
Japanese encephalitis
Measles 62  35  234  1'292  322  1'379  11'441 
Mumps
Pertussis 30  383  7'576 
Polio* 13  159 
Rubella 61 
Rubella (CRS)
Tetanus (neonatal) 16 
Tetanus (total) 24  12 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mauritania)
Vaccine year result method % card seen                                                
BCG 2010  92  MICS   32  95  95  86  85  81  48  79 
DTP1 2010  89  MICS   32  95  95  91  82  79 
DTP3 2010  60  MICS   32  80  80  75  64  64  31  33 
HepB_BD          24 
HepB3 2010  60  MICS   32  80  80  75  64  64 
Hib3 2010  60  MICS   32  80  80  75  64  64 
JapEnc         
MCV 2010  71  MICS   32  80  75  67  67  59  38 
MCV2         
PCV1          23 
PCV3          20 
Pol3 2010  58  MICS   32  80  80  73  52  63  31  33 
Rota1         
Rota_last         
Rubella1         
TT2plus 2010  41  MICS   32  40  40  29  30  29  15 
PAB         
VAD1         
YFV 1988  36  EPI   69  32 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mauritania)
BCG 95  95  86  85  81  78  79 
DTP1 95  95  91  82  79  73  69 
DTP3 80  80  75  64  64  51  33 
HepB3 80  80  75  64  64 
HepB_BD
Hib3 80  80  75  64  64 
MCV 80  75  67  67  59  46  38 
MCV2
PAB 80  80  80  87  87  44  24 
PnC3
Pol3 80  80  73  52  63  58  33 
Rota_last
YFV

Number of districts in the country 53  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 21
From 80 to 89% 21
From 50 to 79% 51
Less than 50% 8
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB birth; Yes
Measles 9 months; Yes
OPV Birth; 6, 10, 14 weeks; Yes
Pneumo_conj , 10, 14 weeks; Yes From November 2013
Td 1st contact or pregnancy; +1, +6 months;+1, +1 year; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   
What years does the MYP cover? number 2012-2015  2012-2015  2012-2015  2008-2012  2008-2012     
Nº of districts with microplans that include activities to raise immunization coverage number 53  53  39  39       

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  Yes  Yes       

System performance

Total Nº districts in country number 53  53  53  53  53  53  53 
Nº districts with DTP3 coverage >=80% number 22  21  15  12  10 
% of districts with DTP3 coverage >=80% From 0 to 100% 42  40  28  17  11  23  19 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100%  

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 16  15  21  11  100    100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.